MDR 5.13% 41.0¢ medadvisor limited

Ann: MedAdvisor 2020 Annual Report & Appendix 4E, page-7

  1. 2,988 Posts.
    lightbulb Created with Sketch. 1136
    You've captured my point much better than my (frustrated) comment

    This communicated previously was not even mentioned....no mention of delays, and what starts when, just broad statements

    The TAM means nothing....they have over 60% of pharmacys in Australia and 1.7m patients....after a decade they have ~10m which is 25%, so imagine what it will take to capture what they are claiming in other markets with a fraction of the Australia penetration.

    Also claiming to want to market themselves to retail shareholders......a bit of honesty and transparency would be a start! Hopefully they see the price reaction today and see the light.....and they need these retail shareholders as they continue to burn money (9m last FY!)


 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.